| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 7, Issue 5 361-366, Copyright © 2000 by Society of Surgical Oncology
ARTICLES |
S. P. Leong, E. Donegan, W. Heffernon, S. Dean and J. A. Katz
Department of Surgery, University of California/Mount Zion Medical Center, San Francisco 94143-1674, USA. leongs@surgery.ucsf.edu
BACKGROUND: Selective sentinel lymph node (SLN) dissection can spare about 80% of patients with primary melanoma from radical lymph node dissection. This procedure identifies the SLN either visually by injecting isosulfan blue dye around the primary melanoma site or by handheld gamma probe after radiocolloid injection. METHODS: During selective SLN mapping, 1 to 5 ml of isosulfan blue was injected intradermally around the primary melanoma. From November 1993, to August 1998, 406 patients underwent intraoperative lymphatic mapping with the use of both isosulfan blue and radiocolloid injection. Three cases of selective SLN dissection, in which adverse reactions to isosulfan blue occurred, were reviewed. RESULTS: We report three cases of anaphylaxis after intradermal injection with isosulfan blue of 406 patients who underwent intraoperative lymphatic mapping by using the procedure as described above. The three cases we report vary in severity from treatable hypotension with urticaria and erythema to severe cardiovascular collapse with or without bronchospasm or urticaria. CONCLUSIONS: In our series, the incidence of anaphylaxis to isosulfan blue was approximately 1%. Anaphylaxis can be fatal if not recognized and treated rapidly. Operating room personnel who participate in intraoperative lymphatic mapping where isosulfan blue is used must be aware of the potential consequences and be prepared to treat anaphylaxis.
This article has been cited by other articles:
![]() |
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Wong, M. S. Brady, K. J. Busam, and D. G. Coit Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma Ann. Surg. Oncol., March 1, 2006; 13(3): 302 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors Arch Surg, November 1, 2004; 139(11): 1180 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Wong, D. S. Johnson, T. Namiki, and P. Tauchi-Nishi Validation of Ex Vivo Lymphatic Mapping in Hematoxylin-Eosin Node-Negative Carcinoma of the Colon and Rectum Ann. Surg. Oncol., August 1, 2004; 11(8): 772 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. King, J. V. Fey, K. J. Van Zee, A. S. Heerdt, M. L. Gemignani, E. R. Port, L. Sclafani, V. Sacchini, J. A. Petrek, H. S. Cody III, et al. A Prospective Analysis of the Effect of Blue-Dye Volume on Sentinel Lymph Node Mapping Success and Incidence of Allergic Reaction in Patients With Breast Cancer Ann. Surg. Oncol., May 1, 2004; 11(5): 535 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Raut, M. D. Daley, K. K. Hunt, J. Akins, M. I. Ross, S. E. Singletary, G. D. Marshall Jr, F. Meric-Bernstam, G. Babiera, B. W. Feig, et al. Anaphylactoid Reactions to Isosulfan Blue Dye During Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis J. Clin. Oncol., February 1, 2004; 22(3): 567 - 568. [Full Text] [PDF] |
||||
![]() |
S. Saha, A. G. Dan, B. Berman, D. Wiese, E. Schochet, K. Barber, S. Choudhri, S. Kaushal, B. Ganatra, D. Desai, et al. Lymphazurin 1% Versus 99mTc Sulfur Colloid for Lymphatic Mapping in Colorectal Tumors: A Comparative Analysis Ann. Surg. Oncol., January 1, 2004; 11(1): 21 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Wrightson, S. L. Wong, M. J. Edwards, C. Chao, D. S. Reintgen, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and K. M. McMasters Complications Associated With Sentinel Lymph Node Biopsy for Melanoma Ann. Surg. Oncol., July 1, 2003; 10(6): 676 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Simmons, S. Thevarajah, M. B. Brennan, P. Christos, and M. Osborne Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization Ann. Surg. Oncol., April 1, 2003; 10(3): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sprung, M. J. Tully, and A. Ziser Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer Anesth. Analg., April 1, 2003; 96(4): 1051 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. L. Leong, M. C. Thelmo, R. P. Kim, R. Gokhale, J. Y. Rhee, T. A. Achtem, E. Morita, R. E. Allen Jr, M. Kashani-Sabet, and R. W. Sagebiel Delayed Harvesting of Sentinel Lymph Nodes After Previous Wide Local Excision of Extremity Melanoma Ann. Surg. Oncol., March 1, 2003; 10(2): 196 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans Sentinel nodal assessment in patients with carcinoma of the lung Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Stefanutto, W. A. Shapiro, and P. M. C. Wright Anaphylactic reaction to isosulphan blue Br. J. Anaesth., September 1, 2002; 89(3): 527 - 528. [Full Text] [PDF] |
||||
![]() |
L. L. Montgomery, A. C. Thorne, K. J. Van Zee, J. Fey, A. S. Heerdt, M. Gemignani, E. Port, J. Petrek, H. S. Cody III, and P. I. Borgen Isosulfan Blue Dye Reactions During Sentinel Lymph Node Mapping for Breast Cancer Anesth. Analg., August 1, 2002; 95(2): 385 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Kuerer, K. K. Hunt, S. E. Singletary, and F. C. Ames Unusual Aspects of Breast Cancer: Case 3. Blue Hives During Lymphatic Mapping for Breast Cancer J. Clin. Oncol., May 1, 2001; 19(9): 2573 - 2574. [Full Text] [PDF] |
||||
![]() |
R. S. Krouse, R. E. Schwarz, and S. P. L. Leong Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive? Ann. Surg. Oncol., April 1, 2001; 8(3): 268 - 269. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |